John Fluke - Cellcyte Genetics Insider

CCYG -- USA Stock  

USD 0.0006  0.00  0.00%

Mr. John M. Fluke, Jr., is Interim Principal Executive Officer and Director of CellCyte Genetics Corporationrationration. He is the Chairman of Fluke Capital Management, LP the Fluke investment and trust management company. He founded the company in 1976. Mr. Fluke graduated from the University of Washington in 1964, with a BS Degree in Electrical Engineering, and received his Master Degree in Electrical Engineering from Stanford University in 1966. Mr. Fluke joined his father firm, John Fluke Mfg. Co., in 1966 as a design engineer and held various engineering and general management positions. He was elected to the board of that company in 1976, appointed Chief Executive Officer in 1983 and Chairman from 1984. He served as CEO through 1987, Chairman through 1990 and a director of the Fluke Corporationration through July 1998 when the company was acquired by Danaher Corporationrationration. Mr. Fluke currently serves on the Boards of two emerging or reemerging companies Metron Systems, Inc. and MaestroSoft, Inc. . Over the last three decades many of Mr. Fluke governance positions with smaller companies have required direct and frequent interaction with management to balance the achievement of cash flow positive performance without deviating from governance practices. He also currently serves as a director of Tully Coffee Company and chairs its audit committee
Age: 71  Chairman Since 2007      
Fluke is a former director and chairman of the audit committee for PRIMUS International and American Seafoods Group where he served on the audit committee. He has also served on the boards and audit committees of Peoples National Bank and US Bank of Washington .

Management Efficiency

The company has return on total asset (ROA) of (415.29) % which means that it has lost $415.29 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (22.9) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Found 6 records


John ThompsonMicrosoft Corporation
Eric SchmidtAlphabet
Jeffrey BezosAmazon
Roberto SampedroEcopetrol S A

Entity Summary

CellCyte Genetics Corporation, a development stage biotechnology company, engages in the research and development of medical devices for cell expansion and maintenance in the United States. The company was founded in 2005 and is based in Bellevue, Washington. Cellcyte Genetics is traded on BATS Exchange in USA.Cellcyte Genetics Corp [CCYG] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Cellcyte Genetics Corp Management Team

John Fluke, Chairman, Interm CEO and Chairman of Audit Committee
Randy Lieber, Principal Accounting Officer, Director
Douglas Cerretti, President, Chief Science Officer and Director of Bus. Devel.

Stock Performance Indicators

Current Sentiment - CCYG

Cellcyte Genetics Corp Investor Sentiment

Macroaxis portfolio users are unresponsive in their opinion about investing in Cellcyte Genetics Corp. What is your opinion about investing in Cellcyte Genetics Corp? Are you bullish or bearish?
50% Bullish
50% Bearish

Cellcyte Genetics Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Cellcyte Genetics and Alamos Gold. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Companies Directory module to evaluate performance of over 100,000 stocks, funds, and etfs against different fundamentals.